Lixte Biotechnology VP and COO Eric Forman resigns effective Dec 31, 2024

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Eric Forman resigned as VP and COO of Lixte Biotechnology Holdings, effective December 31, 2024.
Resignation is for personal reasons; no disagreement with company operations, policies, or practices.
Employment agreement dated July 15, 2020 (amended Aug 12, 2020 and Nov 6, 2022) terminates on Dec 31, 2024.
No replacement or interim appointment has been announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.